Hui Yvonne of Phreesia sells $12,098 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phreesia Inc (PHR)
Phreesia Inc stock price live, this page displays NYSE PHR stock exchange data. View the PHR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Phreesia Inc real time stock price chart below.
What Is the Phreesia Inc Stock Price Today?
The Phreesia Inc stock price today is 16.39.
What Is the Stock Symbol for Phreesia Inc?
The stock symbol for Phreesia Inc is "PHR."
What Stock Exchange Does Phreesia Inc Trade On?
Phreesia Inc is listed and trades on the NYSE stock exchange.
Is Phreesia Inc a Good Stock to Buy?
Determining whether Phreesia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHR quote. (ISIN: US71944F1066)
What Is the Phreesia Inc Stock Price Today?
The Phreesia Inc stock price today is 16.39.
What Is the Stock Symbol for Phreesia Inc?
The stock symbol for Phreesia Inc is "PHR."
What Stock Exchange Does Phreesia Inc Trade On?
Phreesia Inc is listed and trades on the NYSE stock exchange.
Is Phreesia Inc a Good Stock to Buy?
Determining whether Phreesia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHR quote. (ISIN: US71944F1066)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.11
16.55
52 wk Range
15.41
32.76
PHR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.1116.55
52 wk Range
15.4132.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
29.16
Upside
+77.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 144 Phreesia For: 16 January
- Investing.com
- Form 144 Phreesia For: 8 January
- Investing.com
- Form 144 Phreesia For: 15 January
- Investing.com
- Hui Yvonne of Phreesia sells $12,098 in shares
- Investing.com
- Form 144 Phreesia For: 16 January
- Investing.com
- Form 144 Phreesia For: 15 January
- Investing.com
- Phreesia Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Phreesia Inc Company Profile
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients’ mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Phreesia Inc SWOT Analysis
Digital Health Pionee | Explore Phreesia's multifaceted platform revolutionizing patient engagement, administrative efficiency, and pharmaceutical marketing in the evolving healthcare IT landscape |
Financial Momentum | Delve into Phreesia's impressive revenue growth, improving profitability metrics, and transition to positive adjusted EBITDA and free cash flow generation |
Strategic Expansion | Learn how Phreesia's partnerships with large specialty provider networks and diverse revenue streams are driving scalability and market penetration |
Market Outlook | Analyst price targets range from $34 to $35, reflecting confidence in Phreesia's growth potential and its positioning as a "growth-at-a-reasonable-price" opportunity |
Phreesia Inc Earnings Call Summary for Q3/2026
- Phreesia reported Q3 2025 EPS of $0.07, significantly exceeding the forecast of -$0.0014, with revenue of $120.3 million (up 13% YoY), leading to a 2.51% stock increase in aftermarket trading.
- The company achieved its second consecutive quarter of positive net income ($4.3 million) and improved Adjusted EBITDA to $29.1 million, with a 15 percentage point year-over-year margin improvement.
- Operating cash flow increased to $15.5 million (up $9.7 million YoY), while cash and cash equivalents stood at $106.4 million, demonstrating strengthened financial position.
- For fiscal 2027, Phreesia projects revenue between $545-559 million and adjusted EBITDA of $125-135 million, with newly acquired AccessOne expected to contribute 6.5% of revenue.
- CEO Chaim Indig highlighted emerging products as key to sustaining growth, while management noted the company is well-positioned regarding recent regulatory developments in healthcare.
Last Updated: 2025-12-08, 06:08 p/m
Read Full TranscriptCompare PHR to Peers and Sector
Metrics to compare | PHR | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPHRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −183.7x | −8.6x | −0.6x | |
PEG Ratio | −1.96 | −0.02 | 0.00 | |
Price/Book | 3.1x | 2.1x | 2.6x | |
Price / LTM Sales | 2.1x | 2.3x | 3.4x | |
Upside (Analyst Target) | 76.9% | 39.6% | 39.6% | |
Fair Value Upside | Unlock | 24.3% | 5.2% | Unlock |
Analyst Ratings
20 Buy
0 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 29.16
(+77.90% Upside)
Earnings
Latest Release
Dec 08, 2025
EPS / Forecast
0.07 / -0.0014
Revenue / Forecast
120.30M / 119.89M
People Also Watch
FAQ
What Is the Phreesia (PHR) Stock Price Today?
The Phreesia stock price today is 16.39
What Stock Exchange Does Phreesia Trade On?
Phreesia is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Phreesia?
The stock symbol for Phreesia is "PHR."
What Is the Phreesia Market Cap?
As of today, Phreesia market cap is 988.10M.
What Is Phreesia's Earnings Per Share (TTM)?
The Phreesia EPS (TTM) is -0.09.
When Is the Next Phreesia Earnings Date?
Phreesia will release its next earnings report on Apr 01, 2026.
From a Technical Analysis Perspective, Is PHR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Phreesia Stock Split?
Phreesia has split 0 times.
How Many Employees Does Phreesia Have?
Phreesia has 2082 employees.
What is the current trading status of Phreesia (PHR)?
As of Jan 19, 2026, Phreesia (PHR) is trading at a price of 16.39, with a previous close of 16.45. The stock has fluctuated within a day range of 16.11 to 16.55, while its 52-week range spans from 15.41 to 32.76.
What Is Phreesia (PHR) Price Target According to Analysts?
The average 12-month price target for Phreesia is USD29.15789, with a high estimate of USD35 and a low estimate of USD24. 20 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +77.90% Upside potential.
What Is the PHR After Hours Price?
PHR's last after hours stock price is 16.35, the stock has decreased by -0.04, or -0.24%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.